Fact Based List:

Top U.S. Life Science R&D Expenditures for Q1-Q3 2012

  1. Pfizer - $5,734
  2. Merck & Co. - $5,945
  3. Johnson & Johnson - $5,334
  4. Lilly (Eli) & Co. - $3,815
  5. Abbott Laboratories - $3,181
  6. Bristol-Myers Squibb Co. - $2,822
  7. Amgen - $2,411
  8. Celgene - $1,251
  9. Medtronic (estimated) - $1,167
  10. Monsanto - $1,166

Source: Battelle/R&D Magazine
Source URL: http://www.battelle.org/docs/default-document-library/2013-R...
Notes: In millions